Rogelio Zapata-Arenas
Rogelio Zapata-Arenas has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Juan José Díaz-Vintimilla
Secretaría de Salud, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Departamento de Neuropatología. Ciudad de México, México
2 shared publications - Aaron Noe Manjarrez-Reyna
Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico
1 shared publication - Antonio González-Chávez
Servicio de Medicina Interna, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico
1 shared publication - Cruz Flores-Rebollo
Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico
1 shared publication - Fernando Alba-Flores
Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico
1 shared publication - Galileo Escobedo
Laboratorio de Inmunometabolismo, División de Investigación, Hospital General de México, Dr. Eduardo Liceaga, Mexico City, Mexico
1 shared publication
Latest Publications
- Open Access
- 10 October 2022
- Published by Universidad Anahuac Mexico in Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare
- Vol. 2 (4) , 23-28
AIDS-related disseminated Kaposi Sarcoma: a case report
Kaposi sarcoma (KS) is the most common malignant tumor in HIV-infected individuals. Although its most common form consists of skin and mucosal lesions, it can also present itself in a disseminated way affecting the gastrointestinal tract, lungs and eye structures. We present the case of a 27-year-old male patient with HIV infection and disseminated Kaposi sarcoma. Disseminated KS is an uncommon form of the disease. Therefore, it is important to take this into account, particularly in HIV-infected individuals with characteristic cutaneous lesions.
- 10 October 2022
- Published by Universidad Anahuac Mexico in Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare
- Vol. 2 (4) , 23-28
Open AccessAIDS-related disseminated Kaposi Sarcoma: a case report
Kaposi sarcoma (KS) is the most common malignant tumor in HIV-infected individuals. Although its most common form consists of skin and mucosal lesions, it can also present itself in a disseminated way affecting the gastrointestinal tract, lungs and eye structures. We present the case of a 27-year-old male patient with HIV infection and disseminated Kaposi sarcoma. Disseminated KS is an uncommon form of the disease. Therefore, it is important to take this into account, particularly in HIV-infected individuals with characteristic cutaneous lesions.
- Open Access
- 30 September 2021
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 15 (09) , 1359-1363
Subacute transverse myelitis as a clinical presentation of neurobrucellosis
Brucella melitensis is the main cause of human brucellosis worldwide and is considered the most virulent and neurotropic species. In Mexico, this species is considered endemic, being reported since the first decade of the 20th century. Here we present a case of subacute transverse myelitis with the isolation and identification of B. melitensis as the causative agent of Neurobrucellosis in a female patient from the coastal state of Guerrero, Mexico.
- 30 September 2021
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 15 (09) , 1359-1363
Open AccessSubacute transverse myelitis as a clinical presentation of neurobrucellosis
Brucella melitensis is the main cause of human brucellosis worldwide and is considered the most virulent and neurotropic species. In Mexico, this species is considered endemic, being reported since the first decade of the 20th century. Here we present a case of subacute transverse myelitis with the isolation and identification of B. melitensis as the causative agent of Neurobrucellosis in a female patient from the coastal state of Guerrero, Mexico.
- Open Access
- 10 October 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (10) , 1560
The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19)
There is a deep need for mortality predictors that allow clinicians to quickly triage patients with severe coronavirus disease 2019 (Covid-19) into intensive care units at the time of hospital admission. Thus, we examined the efficacy of the lymphocyte-to-neutrophil ratio (LNR) and neutrophil-to-monocyte ratio (NMR) as predictors of in-hospital death at admission in patients with severe Covid-19. A total of 54 Mexican adult patients with Covid-19 that met hospitalization criteria were retrospectively enrolled, followed-up daily until hospital discharge or death, and then assigned to survival or non-survival groups. Clinical, demographic, and laboratory parameters were recorded at admission. A total of 20 patients with severe Covid-19 died, and 75% of them were men older than 62.90 ± 14.18 years on average. Type 2 diabetes, hypertension, and coronary heart disease were more prevalent in non-survivors. As compared to survivors, LNR was significantly fourfold decreased while NMR was twofold increased. LNR ≤ 0.088 predicted in-hospital mortality with a sensitivity of 85.00% and a specificity of 74.19%. NMR ≥ 17.75 was a better independent risk factor for mortality with a sensitivity of 89.47% and a specificity of 80.00%. This study demonstrates for the first time that NMR and LNR are accurate predictors of in-hospital mortality at admission in patients with severe Covid-19.
- 10 October 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (10) , 1560
Open AccessThe Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19)
There is a deep need for mortality predictors that allow clinicians to quickly triage patients with severe coronavirus disease 2019 (Covid-19) into intensive care units at the time of hospital admission. Thus, we examined the efficacy of the lymphocyte-to-neutrophil ratio (LNR) and neutrophil-to-monocyte ratio (NMR) as predictors of in-hospital death at admission in patients with severe Covid-19. A total of 54 Mexican adult patients with Covid-19 that met hospitalization criteria were retrospectively enrolled, followed-up daily until hospital discharge or death, and then assigned to survival or non-survival groups. Clinical, demographic, and laboratory parameters were recorded at admission. A total of 20 patients with severe Covid-19 died, and 75% of them were men older than 62.90 ± 14.18 years on average. Type 2 diabetes, hypertension, and coronary heart disease were more prevalent in non-survivors. As compared to survivors, LNR was significantly fourfold decreased while NMR was twofold increased. LNR ≤ 0.088 predicted in-hospital mortality with a sensitivity of 85.00% and a specificity of 74.19%. NMR ≥ 17.75 was a better independent risk factor for mortality with a sensitivity of 89.47% and a specificity of 80.00%. This study demonstrates for the first time that NMR and LNR are accurate predictors of in-hospital mortality at admission in patients with severe Covid-19.